Company Overview

Company name: Vireo Health (CNQ: VREO)
Description: Vireo Health International Inc is a pharmaceutical company. It is engaged in manufacturing pharmaceutical-grade cannabis and related products. The company sells its products to the company and third-party dispensaries. It sales wide range of vaporizers.
Year founded: 2014
Parent company:
Industry: Healthcare | Group: | Code:
Employees: 350
City: Minneapolis
State: Minnesota
Country: United States

Financial Highlights

Start up capital raised (USD Million): 111.90
Business status: Generating Revenue
Ownership: Publicly Held
Exchange: CNQ
Ticker: VREO
Revenue (USD Million): 20.96
Gross profit (USD Million):
Net income (USD Million) -19.99
Enterprise value: 32.70
Earnings before interest, tax, depreciation and amortization (EBITDA): -18.07
Fiscal period: TTM 3Q2019
Financing Status: The company (CNQ:VREO) received $10 million of development capital from undisclosed investors on March 10, 2020 through a private placement. The Company intends to use the proceeds from the Offering to fund various growth initiatives, as well as for working capital and general corporate purposes. Additional tranches of the Offering may be closed on or before April 17, 2020.
Number of active investors:
Profile last updated: 12-Apr-2020
Last known valuation:
Last known valuation date: